Figure 1
Haemoglobin level variation between baseline (pre-treatment) levels and four weeks after ferric carboxymaltose administration. Each dot represents a value relative to a patient.
Figure 1 | Scientific Reports
Haemoglobin level variation between baseline (pre-treatment) levels and four weeks after ferric carboxymaltose administration. Each dot represents a value relative to a patient.
